AKT question relating to vaginal dryness

2021 ◽  
Vol 14 (10) ◽  
pp. e97-e97
Author(s):  
Anish Kotecha
Keyword(s):  
2014 ◽  
Vol 12 (11) ◽  
pp. 546-551
Author(s):  
Kathy Abernethy
Keyword(s):  

2006 ◽  
Vol 49 (11) ◽  
pp. 3056-3059 ◽  
Author(s):  
Nareshkumar Jain ◽  
Ramesh M. Kanojia ◽  
Jiayi Xu ◽  
Guo Jian-Zhong ◽  
Emmanuel Pacia ◽  
...  

2018 ◽  
Vol 25 (10) ◽  
pp. 1094-1104 ◽  
Author(s):  
L. Elaine Waetjen ◽  
Sybil L. Crawford ◽  
Po-Yin Chang ◽  
Barbara D. Reed ◽  
Rachel Hess ◽  
...  

2017 ◽  
Vol 24 (2) ◽  
pp. 70 ◽  
Author(s):  
Ali Baziad

Objective: To review the diagnosis and management of vaginal dryness in menopausal womenMethods: Literature reviewResults: Lack of estrogen negatively impacts the vagina and the urinary tract. The vagina becomes dry (atrophic) and then causing pain during sexual intercourse. Vaginal atrophy can be diagnosed in the form of vaginal dryness (75%), painful sexual intercourse (38%), itching and discharge complaints. Sometimes the patient complained pain in urinating, frequent night urination, in-continence and recurrent urinary tract infections. Mucose of the cervix, vagina and vulva are thin. Vagina can bleed easi-ly. Diagnosis can also be made by measuring the pH of the vagina by using litmus paper and vaginal cytology. The management involves administration of local estrogen treatment using weak estrogen (E3) in the form of a cream. E3 cream does not need to be combined with progestogen. Other type of local hormonal therapy (TH) is DHEA cream. Giving a strong estrogen (E2) or equin estrogen should always be combined with progestogen to prevent endometrium hyperplasia, either administered locally or systemically. E3 cream is also safe in women with breast cancer who experienced vaginal atrophy.Conclusion: Lack of estrogen causes vaginal atrophy with symptoms of vaginal dryness. Vaginal atrophy also causes urinary problems. Diagnosis is based on symptoms, examination of vaginal pH and vaginal cytology. The management is by adminis-tering HT with estrogen. E3 creams is the most effective in relieving complaints caused by vaginal dryness and complaints caused by the bladder.


2020 ◽  
Vol 49 (8) ◽  
pp. 2951-2961
Author(s):  
Cynthia A. Graham ◽  
Aleksandar Štulhofer ◽  
Theis Lange ◽  
Gert Martin Hald ◽  
Ana A. Carvalheira ◽  
...  

Abstract There has been little comparative, cross-cultural research on sexual difficulties and associated distress, and factors associated with these, among older women. Therefore, the aim of this study was to investigate prevalence rates of sexual difficulties, distress related to these difficulties, and associated sociodemographic, relational, and health factors, among sexually active older women (60–75 years) in committed relationships across four European countries (Norway, Denmark, Belgium, and Portugal). These data could inform us about what differentiates women who do and do not experience distressing sexual difficulties and facilitate the identification of older women who might benefit from clinical interventions as well as the development of new interventions. In total, 1057 women (357 Norwegian; 322 Danish; 237 Belgian; 141 Portuguese) completed a cross-sectional questionnaire assessing six sexual difficulties—vaginal dryness, orgasmic difficulties, lacking interest in sex, lacking enjoyment in sex, pain during sex, and no excitement/arousal during sex—and associated distress. We found a high prevalence of sexual difficulties lasting 3 months or longer in the past year (between 23.5 and 50.2%, depending on the specific difficulty). With the exception of vaginal dryness and pain during sex, however, the majority of women reporting sexual difficulties (50.0% to 86.1%, depending on the specific difficulty) reported no or mild distress. There were relatively few cross-country differences, either in the prevalence of sexual difficulties or related distress. Few sociodemographic or health variables were associated with distressing sexual difficulties, but higher sexual intimacy, higher emotional intimacy, and better mental health were associated with less distress about some sexual difficulties. The findings underline the importance of healthcare professionals asking older women about sexual function and especially associated distress, and suggest that careful attention to the psychological and relationship context of these sexual difficulties is needed, as these could be important targets in the treatment process.


2011 ◽  
Vol 25 (1) ◽  
pp. 13
Author(s):  
Nisarath Soontrapa ◽  
Sukree Soontrapa ◽  
Srinaree Kaewrudee ◽  
Woraluk Somboonporn ◽  
Chuanchom Sakondhavat

<em>Objectives</em>. To determine the prevalence of urogenital symptoms (vaginal dryness, dyspareunia, urinary incontinence) and assess patient’s consultation rate and desire for treatment. <em>Design and Methods.</em> This study was prospective descriptive study, performed with the participation of 125 women who presented in menopausal clinic, Srinagarind Hospital. Women completed the questionnaire including questions about their demographic properties and were interviewed by pre-validated questionnaire and in-depth interview to determine the prevalence of urogenital symptoms, consultation rate and patient’s desire for treatment. <em>Results</em>. The mean age of the participants was 57.1 years. Vaginal dryness was found to be the most common postmenopausal urogenital symptoms (71.2%), followed by urinary incontinence (62.4%) and dyspareunia (52.0%). The consultation rates were 62.2% in vaginal dryness, 46.2% in dyspareunia and 38.5% in urinary incontinence. Patient’s desire for treatment was 66.7% in vaginal dryness, 62.1% in dyspareunia and 53.8% in urinary incontinence. <em>Conclusions</em>. Urogenital symptoms are highly prevalent. Physicians need to improve patient-physician communication and increase their attention to these symptoms and their patient’s attitudes to improve patient’s quality of life.


Sign in / Sign up

Export Citation Format

Share Document